Search research articles
Contact Us
Filters
Showing results (181-190 of 683) with videos related to
Page
of 69
Sort By:
Pharmacoepidemiology and Drug Safety
|
February 7, 2019
Misuse of prescribed opioids in the United States
Ramin Mojtabai, Masoumeh Amin-Esmaeili, Eleeka Nejat, et al.
JAMA
|
January 22, 2020
Trends in Buprenorphine Treatment in the United States, 2009-2018
Mark Olfson, Victoria Shu Zhang, Michael Schoenbaum, et al.
Psychiatric Services (Washington, D.C.)
|
March 18, 2021
Changes in Buprenorphine Treatment After Medicaid Expansion
Mark Olfson, Victoria Shu Zhang, Marissa King, et al.
Anesthesia and Analgesia
|
February 16, 2021
In Response
Caleb Ing, Melanie M Wall, Mark Olfson, et al.
Journal of Affective Disorders
|
January 18, 2006
Health-related quality of life following ECT in a large community sample
W Vaughn McCall, Joan Prudic, Mark Olfson, et al.
The Journal of Clinical Psychiatry
|
February 20, 2013
Trends in office-based treatment of adults with stimulants in the United States
Mark Olfson, Carlos Blanco, Shuai Wang, et al.
The Journal of Clinical Psychiatry
|
February 24, 2026
Trends in Benzodiazepine Prescribing to Adults in the United States: Results From the Medical Expenditure Panel Survey
Mark Olfson, Chandler McClellan, Samuel H Zuvekas, et al.
Journal of Substance Abuse Treatment
|
October 25, 2018
Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees
Hillary Samples, Arthur Robin Williams, Mark Olfson, et al.
JAMA Network Open
|
July 27, 2019
Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder
Ryan S Sultan, Shuai Wang, Stephen Crystal, et al.
Psychiatric Services (Washington, D.C.)
|
September 30, 2021
Variation in Psychotropic Medication Prescription for Adults With Schizophrenia in the United States
Natalie Bareis, Mark Olfson, Melanie Wall, et al.
Page
of 69
Search research articles
Search
Showing results (181-190 of 683) with videos related to
Sort By:
Page
of 69
Pharmacoepidemiology and Drug Safety
|
February 7, 2019
Misuse of prescribed opioids in the United States
Ramin Mojtabai, Masoumeh Amin-Esmaeili, Eleeka Nejat, et al.
JAMA
|
January 22, 2020
Trends in Buprenorphine Treatment in the United States, 2009-2018
Mark Olfson, Victoria Shu Zhang, Michael Schoenbaum, et al.
Psychiatric Services (Washington, D.C.)
|
March 18, 2021
Changes in Buprenorphine Treatment After Medicaid Expansion
Mark Olfson, Victoria Shu Zhang, Marissa King, et al.
Anesthesia and Analgesia
|
February 16, 2021
In Response
Caleb Ing, Melanie M Wall, Mark Olfson, et al.
Journal of Affective Disorders
|
January 18, 2006
Health-related quality of life following ECT in a large community sample
W Vaughn McCall, Joan Prudic, Mark Olfson, et al.
The Journal of Clinical Psychiatry
|
February 20, 2013
Trends in office-based treatment of adults with stimulants in the United States
Mark Olfson, Carlos Blanco, Shuai Wang, et al.
The Journal of Clinical Psychiatry
|
February 24, 2026
Trends in Benzodiazepine Prescribing to Adults in the United States: Results From the Medical Expenditure Panel Survey
Mark Olfson, Chandler McClellan, Samuel H Zuvekas, et al.
Journal of Substance Abuse Treatment
|
October 25, 2018
Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees
Hillary Samples, Arthur Robin Williams, Mark Olfson, et al.
JAMA Network Open
|
July 27, 2019
Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder
Ryan S Sultan, Shuai Wang, Stephen Crystal, et al.
Psychiatric Services (Washington, D.C.)
|
September 30, 2021
Variation in Psychotropic Medication Prescription for Adults With Schizophrenia in the United States
Natalie Bareis, Mark Olfson, Melanie Wall, et al.
Page
of 69